Roche stock soars to 52 week low

Discussion in 'Genentech' started by anonymous, Feb 1, 2018 at 3:38 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    :rolleyes: looking good, confidence high, morale through the roof.
     

  2. anonymous

    anonymous Guest

    Good thing it's a big flu year. TAMIFLU
     
  3. anonymous

    anonymous Guest

    Ouch!
     
  4. anonymous

    anonymous Guest

    Which is available as a generic
     
  5. anonymous

    anonymous Guest

    Roche excels in mediocrity. Everyone knew when they finally gobbled up DNA to keep afloat they would eventually screw it up. And here we are.
     
  6. anonymous

    anonymous Guest

    Is the stock ever going up?
     
  7. anonymous

    anonymous Guest

    Hovering in the 5-year low range, must be all the great clinical data coming out of BioOnc.
     
  8. anonymous

    anonymous Guest

    Ian retiring? I’m fine
    Reorganization? I’m fine
    More changes coming? I’m fine
    Kate R as a VP? Not fine. Now I believe the company is going to hell in a hand basket. Time to get the resume together when they put immature non-leaders who merely chirp what they’ve been told by everyone else doing their work. Run!
     
  9. anonymous

    anonymous Guest

    So are you now telling me that BioOnc is not that special? But the BioOnc CS’s said that they were not replaceable. Damn. Should have sold my stock a long time ago. We’ve been duped.
     
  10. anonymous

    anonymous Guest

    This stock is going down or just stagnating as usual. There are no new brands coming out to drive revenue for many years, and bio similars are only going to erode market share and dollars. As a result management will continue to look for efficiency synergy to cut cost, which entails reduced head count. The stock is not going anywhere for 5 plus years
     
  11. anonymous

    anonymous Guest

    Sad
     
  12. anonymous

    anonymous Guest

    Stock is up!!!!